News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Erin M. Timpe, PharmD

Articles by Erin M. Timpe, PharmD

Evaluation of Angiotensin-Converting Enzyme Inhibitor Use in Patients With Type 2 Diabetes in a State Managed Care Plan

ByErin M. Timpe, PharmD,Naseem Amarshi, PharmD,Pamala J. Reed, DrPH

February 1st 2004

Latest Updated Articles

Evaluation of Angiotensin-Converting Enzyme Inhibitor Use in Patients With Type 2 Diabetes in a State Managed Care Plan
Published: February 1st 2004 | Updated:

Trending on AJMC

Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure

5 Things to Know as Flu Season Begins

FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis

Top 5 Ovarian Cancer Articles of 2025

Time to Progression a Key Prognostic Indicator in R/R DLBCL

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.